A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.

The biotech said some patients developed cancer in a late-stage clinical trial for the bowel-disease drug that was unrelated ...

Gabby Zappia, 37, experienced blood in her stool during her third pregnancy. Months after giving birth, she learned she had ...

A rise in missed symptoms, low fibre intake, ultra-processed foods and delayed screening may be contributing to the growing ...

Scientists have created the most detailed cell map to date showing how genetic variation influences inflammatory bowel ...

Young colon cancer may not be not the same disease doctors are used to treating. Researchers are discovering new links to ...

This symptom is often dismissed, which is why it's so important to recognize.

Integrating a mobile app and online health coaching into usual care improves quality of life and reduces anxiety for patients with IBD.

Researchers have discovered how IBD activates the bone marrow and increases the risk of colon cancer through a key TL1A signal.

​​Patients with IBD commonly experience persistent diarrhea, blood in stools, abdominal pain, weight loss, fatigue, and loss ...

Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently developed innovative antibody drug 9MW5211 has ...

The risk for major adverse cardiovascular events appeared similar between older patients treated with 5-aminosalicylic acid ...